Chételat, Gaël
Arbizu, Javier
Barthel, Henryk
Garibotto, Valentina
Lammertsma, Adriaan A.
Law, Ian
Morbelli, Silvia
van de Giessen, Elsmarieke
Drzezga, Alexander
Article History
First Online: 20 April 2021
Declarations
:
: Institutional Review Board approval was not required because the paper is an Editorial.
: Not applicable.
: GC has received research support from the EU’s Horizon 2020 research and innovation programme (grant agreement number 667696), Inserm, Fondation d’entreprise MMA des Entrepreneurs du Futur, Fondation Alzheimer, Programme Hospitalier de Recherche Clinique, Région Normandie, Association France Alzheimer et maladies apparentées and Fondation Vaincre Alzheimer (all to Inserm), and personal fees from Fondation d’entreprise MMA des Entrepreneurs du Futur.AD reports personal fees and non-financial support from General Electric Healthcare, Life Molecular Imaging (Piramal), Lilly, during the conduct of the study, grants, and personal fees and non-financial support from Siemens Healthcare, outside of the submitted work, and has a PSMA patent pending.JA reports grants from General Electric, Piramal, and Lilly-Avid, personal fees from Biogen and Bayer, personal fees and non-financial support from Araclon and Advanced Accelerator Applications, outside of the submitted work.VG is supported by the Swiss National Science Foundation (projects 320030_169876 and 320030_185028), the Velux foundation (project 1123), the Aetas foundation, and the Association Pour la Recherche sur l’Alzheimer; reports grants from Siemens Healthineers, Life Molecular Imaging, Merck, Cerveau Technologies, Roche, and General Electric Healthcare; and personal fees from Siemens Healthineers and General Electric Healthcare, outside the submitted work.The other authors declare no conflicts of interest.
Free to read: This content has been made available to all.